From October 1997 through October 1999, 132 patients (stage IIIB, 31 patients; stage IV, 101 patients) who received at least one dose of chemotherapy but did not participate in first-line chemotherapy trials were included.
The aim of this study is to evaluate whether 6 weeks of low-protein diet has impact on body composition, inflammatory markers and progression of CKD in nephropathic patients (stage IIIb/IV according to K-DIGO guidelines).
In the MC078E study22, a cohort of consecutive DLBCL patients, stage II IV, from the Mayo Clinic Lymphoma Database treated with standard R-CHOP21 was retrospectively analyzed as a control.
In all cases magnetic resonance images were obtained: according to Steinberg's classification [9] 12 patients had stage III, 25 patients stage IV, 18 patients stage V and 13 patients stage VI.
The oral presentation was for PET in positive sentinel node biopsy patients (stage III data) and the poster/abstract was for PET in stage II data.
This syndrome was hyperacute (median onset eight days [range, 7 to 29] posttransplant) and manifest by severe skin disease (14 patients at stage 3 and one at stage 4), fever (ten patients), and liver (four patients, stage 3-4) or gut (four patients, stage 3-4) involvement.
Only dialyzed patients (stage 3 and 4) with SP predialysis baseline values were included in order to increase homogeneity (n = 56 treated with LC).
In high-risk patients (stage 4 or any stage with N-MYC amplification), chemotherapy schedules with higher dose intensity are recommended.
METHODS AND MATERIALS: A retrospective treatment planning study was performed to compare IMRT and conventional three-dimensional conformal radiation therapy (3D-CRT) for 10 NSCLC patients (Stage I-IIIB).
Postoperative adjuvant chemotherapy with 5-fluorouracil was performed for stage III patients; stage IV patients received palliative chemotherapy.
Clinically, surgical resection remains the most effective treatment for early-stage NSCLC patients (stage I II), with 30% 60% of survival 5 years after intervention [6].
